The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunology-Global Market Insights and Sales Trends 2024
Synopsis
The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.
The global Immunology market size is expected to reach US$ 102790 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Immunology in various end use industries. The expanding demands from the Autoimmune Diseases, Oncology, Organ Transplantation and Others, are propelling Immunology market. Immuno Boosters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunosuppressants segment is estimated at % CAGR for the next seven-year period.
One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body's immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunology covered in this report include AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Bionor Pharma, Celgene, Cellectar Biosciences and eFFECTOR Therapeutics, etc.
The global Immunology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Bionor Pharma
Celgene
Cellectar Biosciences
eFFECTOR Therapeutics
Global Immunology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunology market, Segment by Type:
Immuno Boosters
Immunosuppressants
Global Immunology market, by Application
Autoimmune Diseases
Oncology
Organ Transplantation
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.
The global Immunology market size is expected to reach US$ 102790 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Immunology in various end use industries. The expanding demands from the Autoimmune Diseases, Oncology, Organ Transplantation and Others, are propelling Immunology market. Immuno Boosters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunosuppressants segment is estimated at % CAGR for the next seven-year period.
One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body's immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunology covered in this report include AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Bionor Pharma, Celgene, Cellectar Biosciences and eFFECTOR Therapeutics, etc.
The global Immunology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Bionor Pharma
Celgene
Cellectar Biosciences
eFFECTOR Therapeutics
Global Immunology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunology market, Segment by Type:
Immuno Boosters
Immunosuppressants
Global Immunology market, by Application
Autoimmune Diseases
Oncology
Organ Transplantation
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immunology
1.1 Immunology Market Overview
1.1.1 Immunology Product Scope
1.1.2 Immunology Market Status and Outlook
1.2 Global Immunology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immunology Market Size by Region (2018-2029)
1.4 Global Immunology Historic Market Size by Region (2018-2023)
1.5 Global Immunology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immunology Market Size (2018-2029)
1.6.1 North America Immunology Market Size (2018-2029)
1.6.2 Europe Immunology Market Size (2018-2029)
1.6.3 Asia-Pacific Immunology Market Size (2018-2029)
1.6.4 Latin America Immunology Market Size (2018-2029)
1.6.5 Middle East & Africa Immunology Market Size (2018-2029)
2 Immunology Market by Type
2.1 Introduction
2.1.1 Immuno Boosters
2.1.2 Immunosuppressants
2.2 Global Immunology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immunology Historic Market Size by Type (2018-2023)
2.2.2 Global Immunology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immunology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immunology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immunology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immunology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immunology Revenue Breakdown by Type (2018-2029)
3 Immunology Market Overview by Application
3.1 Introduction
3.1.1 Autoimmune Diseases
3.1.2 Oncology
3.1.3 Organ Transplantation
3.1.4 Others
3.2 Global Immunology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immunology Historic Market Size by Application (2018-2023)
3.2.2 Global Immunology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immunology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immunology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immunology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immunology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immunology Revenue Breakdown by Application (2018-2029)
4 Immunology Competition Analysis by Players
4.1 Global Immunology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunology as of 2022)
4.3 Date of Key Players Enter into Immunology Market
4.4 Global Top Players Immunology Headquarters and Area Served
4.5 Key Players Immunology Product Solution and Service
4.6 Competitive Status
4.6.1 Immunology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Immunology Products, Services and Solutions
5.1.4 AbbVie Immunology Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Immunology Products, Services and Solutions
5.2.4 Amgen Immunology Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 F. Hoffmann-La Roche
5.3.1 F. Hoffmann-La Roche Profile
5.3.2 F. Hoffmann-La Roche Main Business
5.3.3 F. Hoffmann-La Roche Immunology Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Immunology Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Immunology Products, Services and Solutions
5.4.4 Johnson & Johnson Immunology Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Bionor Pharma
5.5.1 Bionor Pharma Profile
5.5.2 Bionor Pharma Main Business
5.5.3 Bionor Pharma Immunology Products, Services and Solutions
5.5.4 Bionor Pharma Immunology Revenue (US$ Million) & (2018-2023)
5.5.5 Bionor Pharma Recent Developments
5.6 Celgene
5.6.1 Celgene Profile
5.6.2 Celgene Main Business
5.6.3 Celgene Immunology Products, Services and Solutions
5.6.4 Celgene Immunology Revenue (US$ Million) & (2018-2023)
5.6.5 Celgene Recent Developments
5.7 Cellectar Biosciences
5.7.1 Cellectar Biosciences Profile
5.7.2 Cellectar Biosciences Main Business
5.7.3 Cellectar Biosciences Immunology Products, Services and Solutions
5.7.4 Cellectar Biosciences Immunology Revenue (US$ Million) & (2018-2023)
5.7.5 Cellectar Biosciences Recent Developments
5.8 eFFECTOR Therapeutics
5.8.1 eFFECTOR Therapeutics Profile
5.8.2 eFFECTOR Therapeutics Main Business
5.8.3 eFFECTOR Therapeutics Immunology Products, Services and Solutions
5.8.4 eFFECTOR Therapeutics Immunology Revenue (US$ Million) & (2018-2023)
5.8.5 eFFECTOR Therapeutics Recent Developments
6 North America
6.1 North America Immunology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immunology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immunology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immunology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immunology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immunology Market Dynamics
11.1 Immunology Industry Trends
11.2 Immunology Market Drivers
11.3 Immunology Market Challenges
11.4 Immunology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
